Literature DB >> 19575506

Non-invasive computerized system for automatically initiating vagus nerve stimulation following patient-specific detection of seizures or epileptiform discharges.

Ali Shoeb1, Trudy Pang, John Guttag, Steven Schachter.   

Abstract

OBJECTIVE: To demonstrate the feasibility of using a computerized system to detect the onset of a seizure and, in response, initiate Vagus nerve stimulation (VNS) in patients with medically refractory epilepsy.
METHODS: We designed and built a non-invasive, computerized system that automatically initiates VNS following the real-time detection of a pre-identified seizure or epileptiform discharge. The system detects these events through patient-specific analysis of the scalp electroencephalogram (EEG) and electrocardiogram (ECG) signals.
RESULTS: We evaluated the performance of the system on 5 patients (A-E). For patients A and B the computerized system initiated VNS in response to seizures; for patients C and D the system initiated VNS in response to epileptiform discharges; and for patient E neither seizures nor epileptiform discharges were observed during the evaluation period. During the 81 hour clinical test of the system on patient A, the computerized system detected 5/5 seizures and initiated VNS within 5 seconds of the appearance of ictal discharges in the EEG; VNS did not seem to alter the electrographic or behavioral characteristics of the seizures in this case. During the same testing session the computerized system initiated false stimulations at the rate of 1 false stimulus every 2.5 hours while the subject was at rest and not ambulating. During the 26 hour clinical test of the system on patient B, the computerized system detected 1/1 seizures and initiated VNS within 16 seconds of the appearance of ictal discharges; VNS did not alter the electrographic duration of the seizure but decreased anxiety and increased awareness during the post-seizure recovery phase. During the same testing session the computerized system did not declare any false detections. SIGNIFICANCE: Initiating Vagus nerve stimulation soon after the onset of a seizure may abort or ameliorate seizure symptoms in some patients; unfortunately, a significant number of patients cannot initiate VNS by themselves following the start of a seizure. A system that automatically couples automated detection of seizure onset to initiation of VNS may be helpful for seizure treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19575506      PMCID: PMC4211613          DOI: 10.1142/S0129065709001938

Source DB:  PubMed          Journal:  Int J Neural Syst        ISSN: 0129-0657            Impact factor:   5.866


  37 in total

1.  Vagus nerve stimulation for medication-resistant generalized epilepsy. E04 VNS Study Group.

Authors:  D Labar; J Murphy; E Tecoma
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

Review 2.  Vagus-nerve stimulation for the treatment of epilepsy.

Authors:  Elinor Ben-Menachem
Journal:  Lancet Neurol       Date:  2002-12       Impact factor: 44.182

3.  Pilot study of trigeminal nerve stimulation (TNS) for epilepsy: a proof-of-concept trial.

Authors:  Christopher M DeGiorgio; Alan Shewmon; Diane Murray; Todd Whitehurst
Journal:  Epilepsia       Date:  2006-07       Impact factor: 5.864

4.  Detecting seizure onset in the ambulatory setting: demonstrating feasibility.

Authors:  Ali Shoeb; John Guttag; Steven Schachter; Donald Schomer; Blaise Bourgeois; S Ted Treves
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2005

5.  A dry electrode for EEG recording.

Authors:  B A Taheri; R T Knight; R L Smith
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1994-05

6.  Epilepsy: accuracy of patient seizure counts.

Authors:  Christian Hoppe; Annkathrin Poepel; Christian E Elger
Journal:  Arch Neurol       Date:  2007-11

7.  Patient-specific seizure onset detection.

Authors:  Ali Shoeb; Herman Edwards; Jack Connolly; Blaise Bourgeois; S Ted Treves; John Guttag
Journal:  Epilepsy Behav       Date:  2004-08       Impact factor: 2.937

Review 8.  Responsive cortical stimulation for the treatment of epilepsy.

Authors:  Felice T Sun; Martha J Morrell; Robert E Wharen
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

9.  Combination of EEG and ECG for improved automatic neonatal seizure detection.

Authors:  Barry R Greene; Geraldine B Boylan; Richard B Reilly; Philip de Chazal; Sean Connolly
Journal:  Clin Neurophysiol       Date:  2007-03-29       Impact factor: 3.708

10.  Detecting epileptic seizures in long-term human EEG: a new approach to automatic online and real-time detection and classification of polymorphic seizure patterns.

Authors:  Ralph Meier; Heike Dittrich; Andreas Schulze-Bonhage; Ad Aertsen
Journal:  J Clin Neurophysiol       Date:  2008-06       Impact factor: 2.177

View more
  6 in total

Review 1.  Improving early seizure detection.

Authors:  Christophe C Jouny; Piotr J Franaszczuk; Gregory K Bergey
Journal:  Epilepsy Behav       Date:  2011-12       Impact factor: 2.937

2.  Summary of the 2016 Partners Against Mortality in Epilepsy (PAME) Conference.

Authors: 
Journal:  Epilepsy Curr       Date:  2016 Nov-Dec       Impact factor: 7.500

Review 3.  The promise of an interneuron-based cell therapy for epilepsy.

Authors:  Joy Y Sebe; Scott C Baraban
Journal:  Dev Neurobiol       Date:  2011-01-01       Impact factor: 3.964

4.  Quickest detection of drug-resistant seizures: an optimal control approach.

Authors:  Sabato Santaniello; Samuel P Burns; Alexandra J Golby; Jedediah M Singer; William S Anderson; Sridevi V Sarma
Journal:  Epilepsy Behav       Date:  2011-12       Impact factor: 2.937

Review 5.  Closed-loop neurostimulation: the clinical experience.

Authors:  Felice T Sun; Martha J Morrell
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

Review 6.  Neural stimulation systems for the control of refractory epilepsy: a review.

Authors:  Matthew D Bigelow; Abbas Z Kouzani
Journal:  J Neuroeng Rehabil       Date:  2019-10-29       Impact factor: 4.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.